1. Home
  2. VS vs TRIB Comparison

VS vs TRIB Comparison

Compare VS & TRIB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Versus Systems Inc.

VS

Versus Systems Inc.

N/A

Current Price

$1.07

Market Cap

7.9M

Sector

Technology

ML Signal

N/A

Logo Trinity Biotech plc

TRIB

Trinity Biotech plc

N/A

Current Price

$6.32

Market Cap

8.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
VS
TRIB
Founded
2013
1992
Country
United States
Ireland
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.9M
8.4M
IPO Year
2017
1996

Fundamental Metrics

Financial Performance
Metric
VS
TRIB
Price
$1.07
$6.32
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 12.5K
8.0K
Earning Date
11-13-2026
06-16-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 75.97
N/A
EPS
N/A
★ N/A
Revenue
★ $2,183,415.00
N/A
Revenue This Year
N/A
$35.89
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 3711.30
N/A
52 Week Low
$0.75
$0.28
52 Week High
$2.47
$14.17

Technical Indicators

Market Signals
Indicator
VS
TRIB
Relative Strength Index (RSI) 40.85 N/A
Support Level $1.01 N/A
Resistance Level $1.18 N/A
Average True Range (ATR) 0.06 0.00
MACD 0.00 0.00
Stochastic Oscillator 19.13 0.00

Price Performance

Historical Comparison
VS
TRIB

About VS Versus Systems Inc.

Versus Systems Inc operates within the technology sector, focusing on engagement-enhancing solutions through its proprietary prizing and promotions platform. This technology enables developers and content creators across streaming, live events, broadcast, gaming, and other media to integrate real-world prizes into their experiences, fostering greater consumer interaction and providing a compelling opportunity for brand partners and advertisers. The company operates in Canada and the USA.

About TRIB Trinity Biotech plc

Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has three segments, namely the Americas, Asia/Africa, and Europe, from which it derives a majority of its revenue from the Americas segment.

Share on Social Networks: